FDA puts drug trial on hold after subject's death
Explore the potential of 2seventy Bio's DARIC T-cell platform in humans for treating acute myeloid leukemia. After a patient death in June, the FDA put
Source: beckershospitalreview.com
Page 23 - T Cell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from T Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In T Cell Today - Breaking & Trending Today
MaxCyte and Vittoria Biotherapeutics sign strategic platform license to advance next generation cellular therapies
MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, and Vittoria Biotherapeutics (Vittoria), a leading edge, gene-edited cell therapeutics company with novel platform technologies poised to develop a pipeline of highly differentiated cellular therapies for both oncology and immunology indications, today announced the signing of a strategic platform license (SPL) of MaxCyte’s Flow Electroporatio...
Source: news-medical.net
Study explores the diverse expression patterns of T cell priming markers across cancers
A recent study explored transcriptomics of T-cell priming markers (TPMs) across different cancers.
Source: news-medical.net
First-in-Class Drug Approved for Heavily Pretreated Myeloma
Talquetamab achieved response rate of over 70% in MonumenTAL-1 study
Source: medpagetoday.com
Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines
Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.
Source: news-medical.net